UK court allows CMA to amend Pfizer/Flynn appeal
A UK appeal court has granted permission for the Competition and Markets Authority to amend its grounds of appeal in the Pfizer/Flynn excessive pricing case, saying the United Brands test needs to be addressed.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10